Showing results (31-40 of 107) with videos related to
Sort By:
Pageof 11
The Journal of Antimicrobial Chemotherapy|December 5, 2012
High-level expression of cyp51B in azole-resistant clinical Aspergillus fumigatus isolatesA Buied, C B Moore, D W Denning, et al.ISRN Ophthalmology|February 21, 2014
Near visual acuity following hyperopic photorefractive keratectomy in a presbyopic age groupMichael Moore, Antonio Leccisotti, Claire Grills, et al.General and Comparative Endocrinology|July 3, 2002
Pineal melatonin secretion, but not ocular melatonin secretion, is sufficient to maintain normal immune responses in Japanese quail (Coturnix coturnix japonica)C B Moore, T D Siopes, C T Steele, et al.Antimicrobial Agents and Chemotherapy|September 19, 2000
In vivo activity of amphotericin B lipid complex in immunocompromised mice against fluconazole-resistant or fluconazole-susceptible Candida tropicalisP A Warn, J Morrissey, C B Moore, et al.Journal of Clinical Microbiology|April 1, 1997
Species differentiation by internally transcribed spacer PCR and HhaI digestion of fluconazole-resistant Candida krusei, Candida inconspicua, and Candida norvegensis strainsS Nho, M J Anderson, C B Moore, et al.Science (New York, N.Y.)|January 30, 1970
Total carbon and nitrogen abundances in lunar samplesC B Moore, C F Lewis, E K Gibson, et al.European Journal of Ophthalmology|February 16, 2010
Phacoemulsification after deep anterior lamellar keratoplastyAntonio Leccisotti, Tahmina Islam, Victoria E McGilligan, et al.Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|August 10, 2010
Spherical aberration and higher order aberrations with Balafilcon A (PureVision) and Comfilcon A (Biofinity)Colm McAlinden, Jonathan E Moore, Victoria E McGilligan, et al.Science (New York, N.Y.)|August 26, 1977
Psoralen-DNA photoreaction: controlled production of mono- and diadducts with nanosecond ultraviolet laser pulsesB H Johnston, M A Johnson, C B Moore, et al.The Journal of Antimicrobial Chemotherapy|March 7, 2007
Flucytosine therapeutic monitoring: 15 years experience from the UKA C Pasqualotto, S J Howard, C B Moore, et al.Pageof 11